Teligent Pharma, Inc. is recalling 13,992 bottles of Lidocaine Hydrochloride Topical Solution USP, 4% (40 mg/mL) distributed by McKesson Corporation dba Sky Packaging. The recall was initiated because the medication was found to be superpotent, meaning it contains a higher concentration of lidocaine than specified on the label. No incidents or injuries have been reported to date in connection with this recall.
Using a superpotent lidocaine solution increases the risk of higher-than-intended absorption, which can lead to lidocaine toxicity and other serious adverse health effects. This is particularly concerning when used on sensitive or compromised skin surfaces.
You have 2 options:
Packaged in 50 mL screw cap bottles, Rx Only. Manufactured by Teligent Pharma, Inc. and distributed by McKesson Corporation dba Sky Packaging.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.